Goldi is a seasoned pharmaceutical executive with over 20 years of experience in CMC development, technical operations, and pharmaceutical R&D. She currently serves as the Vice President, Head of External Alternative CMC Development at Boehringer Ingelheim, where she oversees innovative CMC strategies, global partnerships, and operational excellence.
Goldi’s career spans leadership roles at Pfizer, Otsuka, and Boston Scientific, where she contributed to process development, manufacturing scale-up, and regulatory strategies, driving innovations across global operations.
Goldi holds a Ph.D. in Pharmaceutical Sciences from Northeastern University, and a Master’s in Pharmaceutical Sciences from Jamia Hamdard.